Acer Therapeutics Inc. Stock
Equities
ACER
US00444P1084
Biotechnology & Medical Research
Latest transcript on Acer Therapeutics Inc.
Managers | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Tanya Hayden
COO | Chief Operating Officer | 44 | 21-05-31 |
John M. Klopp
CTO | Chief Tech/Sci/R&D Officer | 50 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Clifton
DFI | Director of Finance/CFO | 51 | Nov. 16 |
Joshua Schafer
BRD | Director/Board Member | 53 | Nov. 16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.22% | 3 M€ | -.--% | - | |
0.22% | 1 M€ | +3.49% | - |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.51% | 22.2B | |
-16.53% | 21.23B | |
-8.77% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |